Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria?


Journal

Current opinion in immunology
ISSN: 1879-0372
Titre abrégé: Curr Opin Immunol
Pays: England
ID NLM: 8900118

Informations de publication

Date de publication:
10 2019
Historique:
received: 30 01 2019
revised: 24 05 2019
accepted: 24 05 2019
pubmed: 28 6 2019
medline: 25 7 2020
entrez: 28 6 2019
Statut: ppublish

Résumé

The limited metabolic resources of a cell represent an intriguing 'conflict of interest' during host-pathogen interactions, as the battle for nutrients might determine the outcome of an infection. To adapt their metabolic needs, innate immune cells such as monocytes, macrophages or dendritic cells reprogram their metabolism upon activation by microbial compounds. In turn, infection by intracellular bacteria provokes metabolic alterations of the host cell that benefit the pathogen. Here, we discuss the state-of-the-art knowledge on metabolic reprogramming of host cells upon activation or infection with intracellular bacteria. The study of the host-driven and pathogen-driven metabolic alterations that seem to co-exist during infection is an emerging field that will define the metabolic pathways that might be targeted to combat infection.

Identifiants

pubmed: 31247377
pii: S0952-7915(18)30128-6
doi: 10.1016/j.coi.2019.05.009
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-123

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Pedro Escoll (P)

Institut Pasteur, Biologie des Bactéries Intracellulaires, UMR 3525, CNRS, Paris, France. Electronic address: pescoll@pasteur.fr.

Carmen Buchrieser (C)

Institut Pasteur, Biologie des Bactéries Intracellulaires, UMR 3525, CNRS, Paris, France. Electronic address: cbuch@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH